{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:58:45Z","timestamp":1781585925760,"version":"3.54.5"},"reference-count":43,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK106341, DK078244 and DK082753"],"award-info":[{"award-number":["DK106341, DK078244 and DK082753"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["BioTechniques"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.2144\/btn-2018-0042","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T09:16:52Z","timestamp":1533806212000},"page":"71-77","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Assay for Galactose-Deficient IgA1 Enables Mechanistic Studies with Primary Cells from IgA Nephropathy Patients"],"prefix":"10.1080","volume":"65","author":[{"given":"Colin","family":"Reily","sequence":"first","affiliation":[{"name":"University of Alabama at Birmingham,Department of Medicine,\rBirmingham,\rAL,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana V","family":"Rizk","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham,Department of Medicine,\rBirmingham,\rAL,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A","family":"Julian","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham,Department of Medicine,\rBirmingham,\rAL,\rUSA"},{"name":"University of Alabama at Birmingham,Department of Microbiology,\rBirmingham,\rAL,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Novak","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham,Department of Microbiology,\rBirmingham,\rAL,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,8,9]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1206793"},{"issue":"9","key":"e_1_3_6_4_1","first-page":"694","article-title":"Intercapillary deposits of IgA\u2013IgG","volume":"74","author":"Berger J","year":"1968","unstructured":"Berger J , HinglaisN. Intercapillary deposits of IgA\u2013IgG. J. Urol. Nephrol. (Paris)74(9), 694\u2013695 (1968).","journal-title":"J. Urol. Nephrol. (Paris)"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.060003969.x"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590031077.x"},{"issue":"2","key":"e_1_3_6_7_1","first-page":"251","article-title":"Double immunofluorescence studies of immunoglobulins, complement components and their control proteins in patients with IgA nephropathy","volume":"32","author":"Tomino Y","year":"1982","unstructured":"Tomino Y , EndohM, NomotoY, SakaiH. Double immunofluorescence studies of immunoglobulins, complement components and their control proteins in patients with IgA nephropathy. Acta Pathol. Jpn.32(2), 251\u2013256 (1982).","journal-title":"Acta Pathol. Jpn."},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2007.10.009"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5535"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012010053"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011050464"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002185"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-012-0306-z"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.361"},{"issue":"6","key":"e_1_3_6_15_1","first-page":"1668","article-title":"Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity","volume":"119","author":"Suzuki H","year":"2009","unstructured":"Suzuki H , FanR, ZhangZet al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J. Clin. Invest.119(6), 1668\u20131677 (2009).","journal-title":"J. Clin. Invest."},{"key":"e_1_3_6_16_1","first-page":"708A","article-title":"Renal immune deposits of patients with IgA nephropathy are enriched for IgG autoantibody specific for galactose-deficient IgA1","volume":"28","author":"Saha MK","year":"2017","unstructured":"Saha MK , RizkD, HallSDet al. Renal immune deposits of patients with IgA nephropathy are enriched for IgG autoantibody specific for galactose-deficient IgA1. J. Am. Soc. Nephrol.28, 708A (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.197"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M110.001834"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-009-0173-7"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/pr200608q"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI74475"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007091052"},{"issue":"2","key":"e_1_3_6_23_1","first-page":"629","article-title":"IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1","volume":"118","author":"Suzuki H","year":"2008","unstructured":"Suzuki H , MoldoveanuZ, HallSet al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J. Clin. Invest.118(2), 629\u2013639 (2008).","journal-title":"J. Clin. Invest."},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006609"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.512277"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00745.x"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0385-8146(98)00047-9"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1159\/000065465"},{"key":"e_1_3_6_29_1","first-page":"197548","article-title":"Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease","author":"Reily C","year":"2014","unstructured":"Reily C , UedaH, HuangZQet al. Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease. J. Immunol. Res.2014, 197548 (2014).","journal-title":"J. Immunol. Res."},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2017.07.002"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099026"},{"issue":"1","key":"e_1_3_6_32_1","first-page":"S49","article-title":"Limit of blank, limit of detection and limit of quantitation","volume":"29","author":"Armbruster DA","year":"2008","unstructured":"Armbruster DA , PryT. Limit of blank, limit of detection and limit of quantitation. Clin. Biochem. Rev.29(Suppl. 1), S49\u201352 (2008).","journal-title":"Clin. Biochem. Rev."},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/40.7.1233"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012284402054"},{"issue":"2","key":"e_1_3_6_35_1","first-page":"419","article-title":"Detection of polymeric IgA in glomeruli from patients with IgA nephropathy","volume":"49","author":"Tomino Y","year":"1982","unstructured":"Tomino Y , SakaiH, MiuraM, EndohM, NomotoY. Detection of polymeric IgA in glomeruli from patients with IgA nephropathy. Clin. Exp. Immunol.49(2), 419\u2013425 (1982).","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"e_1_3_6_36_1","first-page":"527","article-title":"IgA nephropathy: characterization of the polymeric nature of mesangial deposits by in vitro binding of free secretory component","volume":"47","author":"Bene MC","year":"1982","unstructured":"Bene MC , FaureG, DuheilleJ. IgA nephropathy: characterization of the polymeric nature of mesangial deposits by in vitro binding of free secretory component. Clin. Exp. Immunol.47(3), 527\u2013534 (1982).","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1159\/000441852"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-014-1052-4"},{"key":"e_1_3_6_39_1","first-page":"60","article-title":"Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system","volume":"72","author":"Novak J","year":"2011","unstructured":"Novak J , MoldoveanuZ, JulianBAet al. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system. Adv. Otorhinolaryngology72, 60\u201363 (2011).","journal-title":"Adv. Otorhinolaryngology"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00823.x"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.208"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13317-017-0097-2"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2011.10.001"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.16.2.345-349.1982"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.59566\/IJBS.2006.2217"}],"container-title":["BioTechniques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2144\/btn-2018-0042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T19:08:04Z","timestamp":1716318484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2144\/btn-2018-0042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.2144\/btn-2018-0042"],"URL":"https:\/\/doi.org\/10.2144\/btn-2018-0042","relation":{},"ISSN":["0736-6205","1940-9818"],"issn-type":[{"value":"0736-6205","type":"print"},{"value":"1940-9818","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibtn20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibtn20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-04-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}